After scoring a long-awaited FDA approval last fall, Eli Lilly has launched a consumer-facing campaign to get the word out ...
Though the Healthy Skepticism ads don’t specifically call out compounded GLP-1s, Lilly said in a statement to MM+M that ...
Eli Lilly has stepped up its campaign to encourage ... The drugmaker used a 30-second advertising slot that aired during the Oscars ceremony on Sunday to encourage anyone considering sourcing ...
WASHINGTON, D.C. U.S. Senate Democratic Whip Dick Durbin (D-IL) sent letters to five telehealth companies that have held ...
Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive — and covered an exclusive trip for leaders to attend last summer’s ...
While the Super Bowl may not always be the ideal spot for pharma, cultural events like the Oscars can offer a more ...
Eli Lilly’s Ebglyss (lebrikizumab-lbkz) has achieved complete skin clearance after three years in 50% of patients with moderate-to-severe atopic dermatitis (AD) in a Phase III trial. The US ...
Good morning, everyone, and welcome to another working week. We hope the weekend respite was refreshing and reassuring. After all, that oh-so familiar routine of phone calls, online meetings, and ...
The Associated Press on MSN10d
Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli LillyAdvertisement Article continues below this ad Novo said the new pricing is available to both the uninsured and people who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback